Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synergism of Pectin with FMT in Slow Transit Constipation
NCT02291354Phase 2Unknown
- Sponsor
- Jinling Hospital
- Start
- Mar 2015
- Primary completion
- Mar 2016
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Slow-transit constipation (STC) comparing FMT + Placebo with FMT + Pectin (2 arms). Primary endpoint: Proportion of patients having on average three or more spontaneous, complete bowel movements (SCBMs) per week at 12 weeks. Status: unknown.
02
Drugs
pectin
03
Conditions
Slow-transit constipation (STC)
Beyond the preview
Go deeper on NCT02291354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291354.